The Role of Trastuzumab in Patients with HER2 Positive Small (pT1mi/a) Breast Cancers, a Multicenter Retrospective Study

The Role of Trastuzumab in Patients with HER2 Positive Small (pT1mi/a) Breast Cancers, a Multicenter Retrospective Study

The treatment with adjuvant Trastuzumab in patients diagnosed with HER2+ small breast cancers is controversial: limited prospective data from randomized trials is available. This study aims to measure the effect of Trastuzumab in the early stages of breast cancer (pT1mic/a pN0/1mi) in terms of disea...

Full description

Bibliographic Details
Main Authors: Andrea Villasco, Silvia Actis, Valentina Elisabetta Bounous, Fulvio Borella, Marta D’Alonzo, Riccardo Ponzone, Corrado De Sanctis, Chiara Benedetto, Nicoletta Biglia
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cancers
Subjects:
trastuzumab
HER2 positive
pT1mic-pT1a
breast cancer
Online Access:https://www.mdpi.com/2072-6694/13/22/5836

Internet

https://www.mdpi.com/2072-6694/13/22/5836

Similar Items